{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:42:40Z","timestamp":1792460560285,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["125012300658\\u20139"],"award-info":[{"award-number":["125012300658\\u20139"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["FSUS-2025-0012"],"award-info":[{"award-number":["FSUS-2025-0012"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["FWNR-2022\\u20130016"],"award-info":[{"award-number":["FWNR-2022\\u20130016"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003443","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075\\u201300365\\u201325\\u201300"],"award-info":[{"award-number":["075\\u201300365\\u201325\\u201300"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003182","name":"Siberian Branch, Russian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003182","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jpba.2025.117054","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:05:55Z","timestamp":1752591955000},"page":"117054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tissue distribution of OL9-116, a Tdp1 inhibitor based on usnic acid, is significantly altered in Lewis lung carcinoma-bearing mice compared to healthy animals"],"prefix":"10.1016","volume":"265","author":[{"given":"Alina A.","family":"Okhina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana E.","family":"Kornienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem D.","family":"Rogachev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Luzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly A.","family":"Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery P.","family":"Nikolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Zakharenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda S.","family":"Dyrkheeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey G.","family":"Pokrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariman F.","family":"Salakhutdinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga I.","family":"Lavrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117054_bib1","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jamaoncol.2018.1660","article-title":"Estimation of the percentage of US patients with cancer who benefit from genome-driven oncology","volume":"4","author":"Marquart","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jpba.2025.117054_bib2","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.7314\/APJCP.2014.15.13.5305","article-title":"Side effects of chemotherapy among cancer patients in a malaysian general hospital: experiences, perceptions and informational needs from clinical pharmacists","volume":"15","author":"Chan","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.jpba.2025.117054_bib3","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.279.5356.1534","article-title":"A model for the mechanism of human topoisomerase I","volume":"279","author":"Stewart","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jpba.2025.117054_bib4","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3390\/biom5031652","article-title":"Inhibition of topoisomerase (DNA) I (TOP1): DNA damage repair and anticancer therapy","volume":"5","author":"Xu","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpba.2025.117054_bib5","first-page":"1153","article-title":"Targeting Tyrosyl-DNA phosphodiesterase I to enhance toxicity of phosphodiester linked DNA-adducts","volume":"2","author":"Brettrager","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.jpba.2025.117054_bib6","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/acs.jnatprod.6b00979","article-title":"Tyrosyl-DNA phosphodiesterase 1 inhibitors: usnic acid enamines enhance the cytotoxic effect of camptothecin","volume":"79","author":"Zakharenko","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jpba.2025.117054_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10585-021-10113-y","article-title":"The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo","volume":"38","author":"Nikolin","year":"2021","journal-title":"Clin. Exp. Metastas."},{"key":"10.1016\/j.jpba.2025.117054_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10517-019-04413-3","article-title":"Antimetastatic activity of combined topotecan and tyrosyl-DNA phosphodiesterase-1 inhibitor on modeled lewis lung carcinoma","volume":"166","author":"Koldysheva","year":"2019","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.jpba.2025.117054_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115731","article-title":"Pharmacokinetic study of Tdp1 inhibitor resulted in a significant increase in antitumor effect in the treatment of Lewis lung carcinoma in mice by its combination with topotecan","volume":"236","author":"Okhina","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117054_bib10","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.2174\/138161205774580679","article-title":"Drug tissue distribution: study methods and therapeutic implications","volume":"11","author":"Lanao","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jpba.2025.117054_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8837254","article-title":"Determination of crizotinib in mouse tissues by LC-MS\/MS and its application to a tissue distribution study","volume":"2020","author":"Zhao","year":"2020","journal-title":"Int J. Anal. Chem."},{"key":"10.1016\/j.jpba.2025.117054_bib12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1080\/13880209.2021.1990354","article-title":"Simultaneous measurement of tadehaginoside and its principal metabolite in rats by HPLC\u2013MS\/MS and its application in pharmacokinetics and tissue distribution study","volume":"59","author":"Zhang","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.jpba.2025.117054_bib13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s10600-010-9502-z","article-title":"Amino-derivatives of usninic acid","volume":"45","author":"Tazetdinova","year":"2009","journal-title":"Chem. Nat. Compd."},{"key":"10.1016\/j.jpba.2025.117054_bib14","unstructured":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. 22 Sep 2010. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32010L0063 (Accessed on 18 April 2025)."},{"key":"10.1016\/j.jpba.2025.117054_bib15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/cells11071209","article-title":"Extracellular lipids in the lung and their role in pulmonary fibrosis","volume":"11","author":"Burgy","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jpba.2025.117054_bib16","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1007\/s00204-019-02602-7","article-title":"Xenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models","volume":"93","author":"Oesch","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jpba.2025.117054_bib17","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/ph15091158","article-title":"Stability study, quantification method and pharmacokinetics investigation of a coumarin\u2013monoterpene conjugate possessing antiviral properties against respiratory syncytial virus","volume":"15","author":"Nemolochnova","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jpba.2025.117054_bib18","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/dta.3148","article-title":"Stability study of the antiviral agent camphecene in dried blood spots at different temperatures","volume":"13","author":"Okhina","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2025.117054_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113039","article-title":"Development and validation of an LC-MS\/MS method for the quantitative analysis of the anti-influenza agent camphecene in rat plasma and its application to study the blood-to-plasma distribution of the agent","volume":"180","author":"Okhina","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117054_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jflm.2010.12.006","article-title":"Illicit drugs in alternative biological specimens: a case report","volume":"18","author":"Margalho","year":"2011","journal-title":"J. Forensic Leg. Med."},{"key":"10.1016\/j.jpba.2025.117054_bib21","first-page":"S149","article-title":"Analysis of drugs and metabolites in tissues and other solid matrices","author":"James","year":"2004","journal-title":"Chromatographia 59"},{"key":"10.1016\/j.jpba.2025.117054_bib22","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00216-019-02170-w","article-title":"Tissue pretreatment for LC\u2013MS\/MS analysis of PUFA and eicosanoid distribution in mouse brain and liver","volume":"412","author":"Reinicke","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2025.117054_bib23","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.4155\/bio.11.181","article-title":"Evaluation of homogenization techniques for the preparation of mouse tissue samples to support drug discovery","volume":"3","author":"Liang","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.117054_bib24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00216-015-9248-3","article-title":"QuEChERS sample preparation prior to LC-MS\/MS determination of opiates, amphetamines, and cocaine metabolites in whole blood","volume":"408","author":"Dulaurent","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2025.117054_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jchromb.2018.05.033","article-title":"Ractopamine analysis in pig kidney, liver and lungs: a validation of the method scope extension using QuEChERS as a sample preparation step","volume":"1091","author":"Feddern","year":"2018","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2025.117054_bib26","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1080\/19440049.2017.1319075","article-title":"Rapid multiresidue determination of pesticides in livestock muscle and liver tissue via modified QuEChERS sample preparation and LC-MS\/MS","volume":"34","author":"Hamamoto","year":"2017","journal-title":"Food Addit. Contam. Part A"},{"key":"10.1016\/j.jpba.2025.117054_bib27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.aca.2010.09.013","article-title":"Miniaturized salting-out liquid\u2013liquid extraction of sulfonamides from different matrices","volume":"679","author":"Liu","year":"2010","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2025.117054_bib28","unstructured":"U.S. Department of Health and Human Services Food and Drug. Bioanalytical Method Validation Guidance for Industry. May 2018."},{"key":"10.1016\/j.jpba.2025.117054_bib29","unstructured":"EMA Guideline on Bioanalytical Method Validation; Committee for Medicinal Products for Human Use (CHMP). July 2011."},{"key":"10.1016\/j.jpba.2025.117054_bib30","doi-asserted-by":"crossref","unstructured":"H. L\u00fcllmann, K. Mohr, L. Hein, eds., Taschenatlas Pharmakologie, (2015). https:\/\/doi.org\/10.1055\/b-002-99155.","DOI":"10.1055\/b-0034-101029"},{"key":"10.1016\/j.jpba.2025.117054_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmpb.2010.03.007","article-title":"Modelling the double peak phenomenon in pharmacokinetics","volume":"104","author":"Godfrey","year":"2011","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.jpba.2025.117054_bib32","first-page":"381","article-title":"Pharmacokinetic studies of anticancer drugs in tumor-bearing animals","volume":"68","author":"Donelli","year":"1984","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.jpba.2025.117054_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00254171","article-title":"Alterations in plasma pharmacokinetics of cisplatin in tumor-bearing rats","volume":"22","author":"Litterst","year":"1988","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.jpba.2025.117054_bib34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00280-009-1068-8","article-title":"Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents","volume":"65","author":"O\u2019Reilly","year":"2009","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.jpba.2025.117054_bib35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0022-3565(24)36521-8","article-title":"Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol)","volume":"280","author":"Parr","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpba.2025.117054_bib36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.nano.2015.10.012","article-title":"Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells","volume":"12","author":"Kim","year":"2016","journal-title":"Nanomedicine"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525003954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525003954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:07:47Z","timestamp":1777572467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525003954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":36,"alternative-id":["S0731708525003954"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117054","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue distribution of OL9-116, a Tdp1 inhibitor based on usnic acid, is significantly altered in Lewis lung carcinoma-bearing mice compared to healthy animals","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117054"}}